| Literature DB >> 26817016 |
Mani Habibi1, Osman Zekai Oner2, Mehmet Tahir Oruc2, Nurullah Bulbuller3, Sebahat Ozdem4, Sukru Ozdemir5, Arsenal Sezgin Alikanooglu6, Rojbin Karakoyun2, Ugur Dogan2, Ayper Ongen2, Umit Koc2.
Abstract
PURPOSE: Anastomotic leakage in colorectal surgery is a very important issue. Although many studies have shown the positive effects of enteral glutamine (Gln) on anastomotic healing, none has assessed the effects of administering Gln via an enema for anastomotic healing. To fill this study gap, this study investigated the intraluminal effect of administration of Gln enema on the healing of colonic anastomosis in a rat model.Entities:
Keywords: Anastomotic Leak; Enema; Glutamine; Hydroxyproline; Surgical anastomosis
Year: 2015 PMID: 26817016 PMCID: PMC4724702 DOI: 10.3393/ac.2015.31.6.213
Source DB: PubMed Journal: Ann Coloproctol ISSN: 2287-9714
Fig. 1Administration of glutamine enema.
Fig. 2Monitoring of bursting pressure.
Anastomotic bursting pressure
Group I, control group; group II, daily placebo enemas containing physiological saline; group III, daily 2% L-glutamine enemas.
SD, standard deviation.
aOne-way analysis of variance.
Results of a comparison of biochemical measurements
Values are presented as mean ± standard deviation.
Group I, control group; group II, daily placebo enemas containing physiological saline; group III, daily 2% L-glutamine enemas.
TAS, total antioxidant status; TOS, total oxidant status; AOPP, advanced oxidation protein product.
aKruskal-Wallis test. bone-way analysis of variance. *P < 0.05.
Results of an analysis of the significant differences in biochemical measurements among the study groups
Group I, control group; group II, daily placebo enemas containing physiological saline; group III, daily 2% L-glutamine enemas.
TAS, total antioxidant status; TOS, total oxidant status.
aBonferroni-Dunn gest (adjusted values). bTukey test. *P < 0.05.
Results of comparison results of group score values
Values are presented as mean ± standard deviation.
Group I, control group; group II, daily placebo enemas containing physiological saline; group III, daily 2% L-glutamine enemas.
PMN, polymorphonuclear leukocyte.
aAll comparisons performed using the Kruskal-Wallis test.